Advertisement
Home »

KARDIA-2: Add-On Zilebesiran Effectively Lowers Blood Pressure

Apr 26, 2024

REFERENCES & ADDITIONAL READING

Bakris GL, et al. RNA interference with zilebesiran for mild to moderate hypertension: the KARDIA-1 randomized clinical trial. JAMA. 2024;331(9):740-749. doi:10.1001/jama.2024.0728

Bakris GL, et al. Zilebesiran in Combination with a Standard-of-care Antihypertensive in Patients with Inadequately Controlled Hypertension: Primary Results from the Phase 2 KARDIA-2 Study. LB2, Session 405. Presented at: ACC 2024 Scientific Session, April 6–8, 2024, Atlanta, GA.

 

 

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement